Imaging criteria across pivotal randomized controlled trials for late window thrombectomy patient selection.
Bijoy K MenonJohanna Maria OspelRyan A McTaggartRaul G NogueiraAndrew M DemchukAlexandre PoppeJeremy L RempelCharlotte ZernaManish JoshiMohammed A AlmekhlafiThalia S FieldDariush DowlatshahiBrian Anthony van AdelEric SauvageauJason TarpleyTiago MoreiraOh Young BangDonald V HeckMarios N PsychogiosMichael TymianskiMichael D HillMayank Goyalnull nullPublished in: Journal of neurointerventional surgery (2020)
Patients enrolled beyond 6 hours from LKW in the ESCAPE-NA1 trial based on NCCT-ASPECTS and mCTA had similar clinical outcomes when compared with patients selected by perfusion imaging in the DAWN and DEFUSE-3 trials.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- high resolution
- randomized controlled trial
- peritoneal dialysis
- prognostic factors
- clinical trial
- magnetic resonance
- systematic review
- magnetic resonance imaging
- study protocol
- mass spectrometry
- patient reported
- phase iii
- acute ischemic stroke
- contrast enhanced